Ngā hua rapu - C. Chaignot
- E whakaatu ana i te 1 - 2 hua o te 2
-
1
-
2
Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients betwee... mā C. Chaignot, Mahmoud Zureik, Grégoire Rey, Rosemary Dray‐Spira, Joël Coste, Alain Weill
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cohort
Internal medicine
Medicine
Acamprosate
Agonist
Alcohol
Alcohol use disorder
Antibody
Baclofen
Biochemistry
Chemistry
Cohort study
Confidence interval
Hazard ratio
Human papillomavirus
Immunization
Immunology
Incidence (geometry)
Nalmefene
Naltrexone
Opioid
Optics
Pediatrics
Physics
Receptor
Vaccination
Young adult